b>j)΄!Pԫ&;"kB޶}pSVT(wę!j x;-m@JnQ+պכ7MajfJͱ4jѲ撆RxZMz7vIW/dٞТזcZM~ji ߒsQzԠDW3Den"M+/B:-uIJ7j委9p='mANޭ=/B:-n&nUfqxZM~c Ϲ+,&ᾺܢF[(1*" ϒ"Jԧ<;b" "jܢF[x ,!q қ*]/؝27SMcs"ޭDQ/应ܢF_! :s" 7`F+SVTn"IJnQ/应B 4 wD"IJ׭-`S9DrjiEJ߅gJ应矁[xZM~n"IB؃!'Тѕ+(mIKʭ/|ϐܢF[xZMzG %嬩/c[[Buy Orencia Online
\nBuy Orencia online to support advanced arthritis care with a biologic therapy that targets the immune system\u2019s T-cells. Orencia offers a treatment option when prior disease-modifying antirheumatic drugs (DMARDs) have not achieved adequate control. It helps reduce joint swelling, pain and damage, and can be administered as a weekly injection or an infusion under doctor supervision.
\nWhat Is Orencia
\nOrencia (generic: abatacept) is a selective co-stimulation modulator, a type of biologic-immunosuppressant medicine. It works by binding to CD80 and CD86 molecules on antigen-presenting cells, preventing the second \u201ccostimulatory\u201d signal needed for full T-cell activation. Without that signal, T-cells are less able to drive the inflammation and joint damage seen in autoimmune arthritis.
\nDosages and Strengths
\nOrencia is available in several formulations:
\n \u2022 Intravenous infusion form (dose based on weight; often 10 mg\/kg)
\n \u2022 Subcutaneous injection: pre-filled syringes or auto-injector pens containing 87.5 mg\/0.7 mL, 125 mg\/1 mL etc
\nYour physician will select the appropriate form, dosage and schedule based on your condition (rheumatoid arthritis, psoriatic arthritis or juvenile idiopathic arthritis), body weight and other treatments.
\nHow It Works
\nOrencia interrupts the immune process by targeting the second signal required for T-cell activation. In autoimmune arthritis, T-cells mistakenly target healthy joint tissue, causing inflammation, pain, swelling and eventual joint damage. By blocking CD80\/CD86, Orencia helps reduce T-cell activation, lowering inflammation, slowing joint deterioration and improving function.
\nUses and Indications
\nOrencia is approved for:
\n \u2022 Moderate to severe active rheumatoid arthritis (RA) in adults when one or more DMARDs (including methotrexate) or TNF inhibitors have not given sufficient response.
\n \u2022 Active psoriatic arthritis (PsA) in adults when previous DMARD therapy has been inadequate.
\n \u2022 Polyarticular juvenile idiopathic arthritis (pJIA) in children from age 2 years onwards, when other treatments have been insufficient.
\nTreatment should be initiated and supervised by a specialist experienced in managing autoimmune arthritis.
\nDosage and Administration
\n \u2022 For IV infusion form: given at baseline, then at week 2 and week 4, then every 4 weeks thereafter.
\n \u2022 For subcutaneous injection: often once weekly, with a fixed dose (e.g., 125 mg) regardless of weight in adult patients.
\n \u2022 The first dose may be an infusion followed by subcutaneous injections in some cases.
\n \u2022 Ensure you follow your doctor\u2019s instructions strictly for injection technique, schedule and aseptic practice.
\n \u2022 Do not adjust dose or stop treatment without consulting your healthcare provider.
\nStorage Information
\n \u2022 Store pre-filled syringes\/pens or vials in a refrigerator at 2-8 \u00b0C. Do not freeze.
\n \u2022 Keep in original packaging until use.
\n \u2022 After removal for administration, syringes may be kept at room temperature for a limited time as instructed.
\n \u2022 Keep out of reach of children.
\nSide Effects
\nAs with all immunosuppressive therapies, Orencia may cause side effects.
\nCommon side effects: upper respiratory tract infections (common cold), headache, injection site reactions.
\nLess common side effects: increased blood pressure, cough, stomach pain or diarrhoea, elevated liver enzymes.
\nSerious side effects (rare): serious infections (including tuberculosis, fungal infections, opportunistic infections), allergic reactions, infusion reactions, possible malignancies, rare neurologic events (e.g., PML).
\nContact your doctor immediately if you experience signs of infection (fever, chills, cough), breathing difficulties, new or worsening neurologic symptoms, or allergic reaction.
\nPrecautions and Warnings
\n \u2022 Do not use Orencia if you have a serious infection (active or uncontrolled), or are allergic to abatacept or any ingredients.
\n \u2022 Screening for latent tuberculosis, hepatitis and vaccination status should be completed before starting therapy.
\n \u2022 Live vaccines should not be given concurrently with Orencia; inform your doctor of all vaccinations.
\n \u2022 Use caution if you have a history of COPD, chronic infections, liver or heart issues, or you are pregnant or breastfeeding \u2014 discuss risks and benefits with your doctor.
\n \u2022 While on Orencia, maintain regular monitoring including liver and kidney function tests, blood counts and infection indicators.
\n \u2022 Do not donate blood while on immunosuppressive treatment unless recommended by your doctor.
\n \u2022 Avoid combining Orencia with other biologic disease-modifying agents unless under specialist supervision due to increased infection risk.
\nDrug Interactions
\n \u2022 Concurrent use with TNF-alpha inhibitors has shown increased risk of infection and is generally not recommended.
\n \u2022 Live vaccines should not be administered while on Orencia.
\n \u2022 Always inform your healthcare provider about all prescription, over-the-counter medicines, vitamins and herbal supplements.
\nOverdose Information
\nIn case of accidental overdose, monitor for increased rate or severity of adverse events \u2014 especially infections or hypersensitivity reactions. The patient should be monitored carefully and supportive treatment given as needed.<\/p>\n","protected":false},"excerpt":{"rendered":"

Orencia is a prescription injectable medicine used to treat moderate to severe active rheumatoid arthritis, psoriatic arthritis, and juvenile idiopathic arthritis by blocking key immune signals that cause joint inflammation.<\/p>\n","protected":false},"featured_media":0,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[197],"product_tag":[297],"class_list":{"0":"post-46371","1":"product","2":"type-product","3":"status-publish","5":"product_cat-brand","6":"product_tag-rheumatoid-arthritis","7":"product_group-immunological","8":"dosage-250-mg","9":"package_size-1-vial","10":"country_of_origin-canada","11":"active_ingredients-abatacept","13":"first","14":"instock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable"},"acf":[],"_links":{"self":[{"href":"https:\/\/onlinepharmacy.co\/index.php?rest_route=\/wp\/v2\/product\/46371","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/onlinepharmacy.co\/index.php?rest_route=\/wp\/v2\/product"}],"about":[{"href":"https:\/\/onlinepharmacy.co\/index.php?rest_route=\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/onlinepharmacy.co\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=46371"}],"wp:attachment":[{"href":"https:\/\/onlinepharmacy.co\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=46371"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/onlinepharmacy.co\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_brand&post=46371"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/onlinepharmacy.co\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_cat&post=46371"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/onlinepharmacy.co\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_tag&post=46371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}